Fraxinus latifolia pollen

Identification

Name
Fraxinus latifolia pollen
Accession Number
DB10723
Description

Fraxinus latifolia pollen is the pollen of the Fraxinus latifolia plant. Fraxinus latifolia pollen is mainly used in allergenic testing.

Type
Biotech
Groups
Approved
Biologic Classification
Allergenics
Allergen Extract
Synonyms
  • Oregon ash pollen extract

Pharmacology

Indication
Not Available
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Oregon AshInjection, solution20000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
Oregon AshInjection, solution0.05 g/1mLIntradermal; SubcutaneousAntigen Laboratories, Inc.1974-04-23Not applicableUs
Oregon AshInjection, solution0.05 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
Oregon AshInjection, solution40000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
Oregon AshInjection, solution10000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
Oregon AshInjection, solution0.05 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
Oregon AshInjection, solution0.1 g/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
Oregon AshInjection, solution20000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
Oregon AshInjection, solution10000 [PNU]/1mLIntradermal; SubcutaneousNelco Laboratories, Inc.1972-08-29Not applicableUs
Oregon Ash PollenSolution0.05 g/1mLIntradermal; Percutaneous; SubcutaneousGreer Laboratories, Inc.1981-09-15Not applicableUs
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Washington/Oregon Coastal Tree MixtureFraxinus latifolia pollen (0.0056 g/1mL) + Alnus rhombifolia pollen (0.0056 g/1mL) + Betula occidentalis pollen (0.0056 g/1mL) + Juglans nigra pollen (0.0056 g/1mL) + Juglans regia pollen (0.0056 g/1mL) + Pinus contorta pollen (0.0056 g/1mL) + Populus balsamifera subsp. trichocarpa pollen (0.0056 g/1mL) + Quercus garryana pollen (0.0056 g/1mL) + Salix lucida ssp. lasiandra pollen (0.0056 g/1mL)Injection, solutionIntradermal; SubcutaneousAntigen Laboratories, Inc.1996-07-12Not applicableUs
Washington/Oregon Inland Tree MixtureFraxinus latifolia pollen (0.0056 g/1mL) + Acer negundo pollen (0.0056 g/1mL) + Alnus rhombifolia pollen (0.0056 g/1mL) + Betula occidentalis pollen (0.0056 g/1mL) + Pinus contorta pollen (0.0056 g/1mL) + Pinus ponderosa pollen (0.0056 g/1mL) + Populus balsamifera subsp. trichocarpa pollen (0.0056 g/1mL) + Populus tremuloides pollen (0.0056 g/1mL) + Salix lucida ssp. lasiandra pollen (0.0056 g/1mL)Injection, solutionIntradermal; SubcutaneousAntigen Laboratories, Inc.1996-07-12Not applicableUs

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
1FH355G8HF
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347910853
RxNav
900045

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntradermal; Subcutaneous0.05 g/1mL
Injection, solutionIntradermal; Subcutaneous0.1 g/1mL
Injection, solutionIntradermal; Subcutaneous10000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous20000 [PNU]/1mL
Injection, solutionIntradermal; Subcutaneous40000 [PNU]/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.001 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.05 g/1mL
SolutionIntradermal; Percutaneous; Subcutaneous0.1 g/1mL
Injection, solutionIntradermal; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on December 01, 2015 13:04 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates